title: Clopidogrel results in favourable changes in nitric oxide metabolism in patients undergoing percutaneous coronary intervention.
authors.forename: Shantu
authors.initials: S
authors.lastname: Bundhoo
authors.forename: Ewelina
authors.initials: E
authors.lastname: Sagan
authors.forename: Philip E
authors.initials: PE
authors.lastname: James
authors.affiliation: Richard A. Anderson, Cardiovascular Biology and Metabolism, The Institute of Molecular and Experimental Medicine, School of Medicine, Cardiff University, Wales Heart Research Institute, Heath Park, Cardiff, Wales, CF14 4XN, UK, Tel.: +44 2920743786, Fax: +44 2920744473, E-mail: RAAnderson@tiscali.co.uk.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Anderson
mesh_terms: D015415:Biomarkers / Q000097:blood; D000077144:Clopidogrel; D003324:Coronary Artery Disease / Q000097:blood / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006152:Cyclic GMP / Q000097:blood; D006801:Humans; D009566:Nitrates / Q000097:blood; D009569:Nitric Oxide / Q000097:blood*; D009573:Nitrites / Q000097:blood; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011446:Prospective Studies; D015607:Stents; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome; D014664:Vasodilation / Q000187:drug effects; D014852:Wales
chemical_list: D015415:Biomarkers; D009566:Nitrates; D009573:Nitrites; D010975:Platelet Aggregation Inhibitors; D009569:Nitric Oxide; D000077144:Clopidogrel; D006152:Cyclic GMP; D013988:Ticlopidine